← All stocks

BELITE BIO, INC

BLTE Scheduled selling only

CIK 0001889109 #1178 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$31.89M

$31.89M on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 38 sales

Net

−$31.89M

$0.00 against sales at will

By person

5 insiders · 38 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lin Yu-Hsin

Chief Executive Officer

—

$19.08M (19) scheduled

−$19.08M

253,083

0.6433%

$50.12M

−28.3%

Chuang Hao-Yuan

Chief Financial Officer

—

$12.80M (19) scheduled

−$12.80M

231,302

0.5880%

$45.81M

−21.7%

Scholl Hendrik Peter

Chief Medical Officer

—

15,000

0.0381%

$2.97M

−57.1%

Chen Wan-Shan

Director

—

9,096

0.0231%

$1.80M

−10.8%

MATA NATHAN L.

Chief Scientific Officer

—

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 38

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 2 Apr 2026